Abstract Acute Myeloid Leukaemia (AML) with t (8; 21)(q22; 22) is a distinct, rare type of
AML, generally occurs in young patients which has a favorable prognosis. It is found in …

Introduction The transformation of acute myeloid leukemia with translocation (16; 16)(p13;
q22) from AML M2 to acute monocytic leukemia (AML M5) during therapy is a rare clinical …

Only a small number of reports have described the cytogenetic analysis of minimally
differentiated acute myeloid leukemia (AML, MO). We performed a cytogenetic analysis on a …

The present study reviewed three patients with acute myeloid leukemia (AML) who had the
specific genetic abnormality t (16; 21)(p11; q22). To investigate the clinical and laboratory …

Cytogenetic abnormalities occur in approximately 60% of newly diagnosed patients with
acute myeloid leukaemia (AML) and are useful in the risk stratification of AML. Translocation …

Diagnosis of acute myeloid leukemia (AML) is currently made by bone marrow cytology and
is significantly augmented by immunophenotypic and molecular genetic studies. Pre …

Objective To report two de novo acute myeloid leukemia (AML) patients with t (11; 22)(q23;
q11. 2) and summarize the clinical and biological characteristics. Methods Bone marrow …

We present a novel, rare but recurrent variant three way translocation of t (8; 21), t (8; 16;
21)(q22; q24; q22), as a primary cytogenetic abnormality, resulting in AML1/ETO fusion …

Acute myeloid leukaemia (AML) is a type of heterogeneous disease derived from
haematopoietic stem cells. Cytogenetic characterisation is essential for diagnosis and …

ABSTRACT The t (8; 21)(q22; q22) is a frequently occurring aberration in acute myeloid
leukemia (AML)(18-20%) and usually correlate with French-America-British (FAB) M2 …